Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 26;13(10):1729.
doi: 10.3390/genes13101729.

Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients

Affiliations

Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients

Abozer Y Elderdery et al. Genes (Basel). .

Abstract

Introduction: Metabolism methionine and of folate play a vital function in cellular methylation reactions, DNA synthesis and epigenetic process.However, polymorphisms of methionine have received much attention in recent medical genetics research. Objectives: To ascertain whether the common polymorphisms of the MTRR (Methionine Synthase Reductase) A66G gene could play a role in affecting susceptibility to Chronic Myeloid Leukemia (CML) in Sudanese individuals. Methods: In a case-controlled study, we extracted and analyzed DNA from 200 CML patients and 100 healthy control subjects by the PCR-RFLP method. Results: We found no significant difference in age orgender between the patient group and controls. The MTRR A66G genotypes were distributed based on the Hardy-Weinberg equilibrium (p > 0.05). The variation of MTRR A66G was less significantly frequent in cases with CML (68.35%) than in controls (87%) (OR = 0.146, 95% CI = 0.162−0.662, p < 0.002). Additionally, AG and GG genotypes and G allele were reducing the CML risk (Odds ratio [OR] = 0.365; 95% CI [0.179−0.746]; p = 0.006; OR = 0.292; 95% CI [0.145−0.590]; p = 0.001 and OR = 0.146; 95% CI [0.162−0.662]; p = 0.002 and OR = 2.0; 95% CI [1.3853−2.817]; respectively, (p = 0.000)). Conclusions: Our data demonstrated that heterozygous and homozygous mutant genotypes of MTRR polymorphisms were associated with decreased risk of developing CML in the Sudanese population.

Keywords: CML; MTRR; Sudanese population; folate and genetic polymorphism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Representative PCR products and PCR-RFLP analysis of MTRR A66G. (a) PCR products of MTRR A66G: Lane 1 is a 50 base-pair ladder. Lanes 2–7 and 8 show the 66 bp PCR products. (b) PCR-RFLP analysis of MTRR A66G polymorphism using Nde1I restriction enzyme: Lane 1depicts the DNA molecular weight marker with a 50 base-pair ladder. Lanes 2, 4, and 7 show Homozygous wild-type (AA) one band at 44 bp (band 22 bp didnot appear due to its small molecular size). Lane 3 shows the Heterozygous (AG) two bands 66 and 44(also band 22 bp didnot appear due to its small molecular size). Lanes 5 and 6 show a Homozygous mutant (GG) one band 66 bp.

References

    1. Soverini S., Mancini M., Bavaro L., Cavo M., Martinelli G. Chronic myeloid leukemia: The paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy. Mol. Cancer. 2018;17:49. doi: 10.1186/s12943-018-0780-6. - DOI - PMC - PubMed
    1. Jaitly V., Wang W., Hu S. Philadelphia chromosome-negative acute myeloid leukemia with 11q23/MLL translocation in a patient with chronic myelogenous leukemia. Stem Cell Investig. 2015;2:13. - PMC - PubMed
    1. Kang Z.-J., Liu Y.-F., Xu L.-Z., Long Z.-J., Huang D., Yang Y., Liu B., Feng J.-X., Pan Y.-J., Yan J.-S., et al. The Philadelphia chromosome in leukemogenesis. Chin. J. Cancer. 2016;35:48. doi: 10.1186/s40880-016-0108-0. - DOI - PMC - PubMed
    1. Jabbour E., Kantarjian H. Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management. Am. J. Hematol. 2014;89:547–556. doi: 10.1002/ajh.23691. - DOI - PubMed
    1. Hao T., Li-Talley M., Buck A., Chen W. An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States. Sci. Rep. 2019;9:12070. doi: 10.1038/s41598-019-48445-1. - DOI - PMC - PubMed

Publication types

MeSH terms